George et al. generated adult neuroblastoma cell lines with ATRX mutations through this technology, which not only facilitated a thorough investigation into the relationship between poor prognosis and ATRX mutations but also enabled the design of innovative therapeutic approaches (George et al., 2020). The gene discussed is ATRX; the disease is neuroblastoma.